We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 13.22% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Financials | 7.66% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
BioMarin Pharmaceuticals
BMRN
$11.8B
| $6.91M | 0.01% |
79,069
-352,274
| -82% | -$31.5M |
|
|
FYBR
852
DELISTED
Frontier Communications
FYBR
| $6.88M | 0.01% |
+281,012
| New | +$6.65M |
|
853
Melco Resorts & Entertainment
MLCO
$2.17B
| $6.87M | 0.01% |
952,430
-345,689
| -27% | -$2.77M |
|
|
MPT
854
Medical Properties Trust
MPT
$2.91B
| $6.86M | 0.01% |
+1,459,900
| New | +$5.59M |
|
855
ONE Gas
OGS
$5.04B
| $6.83M | 0.01% |
105,830
+10,679
| +11% | +$655K |
|
856
Janus International
JBI
$727M
| $6.77M | 0.01% |
447,713
-2,012,031
| -82% | -$29.2M |
|
857
The Honest Company
HNST
$422M
| $6.77M | 0.01% |
1,671,117
+251,467
| +18% | +$848K |
|
858
BP
BP
$110B
| $6.76M | 0.01% |
179,531
+112,230
| +167% | +$4.02M |
|
859
CALL
UnitedHealth
UNH
$379B
| $6.73M | 0.01% |
13,100
+9,400
| +254% | +$4.78M |
|
860
Telephone and Data Systems
TDS
$3.85B
| $6.72M | 0.01% |
419,692
-465,563
| -53% | -$7.95M |
|
861
Comstock Resources
CRK
$3.82B
| $6.72M | 0.01% |
724,158
+705,439
| +3,769% | +$5.8M |
|
|
INFN
862
DELISTED
Infinera Corporation Common Stock
INFN
| $6.7M | 0.01% |
1,110,973
-639,153
| -37% | -$3.21M |
|
|
VZIO
863
DELISTED
VIZIO Holding Corp.
VZIO
| $6.64M | 0.01% |
606,929
+591,865
| +3,929% | +$5.43M |
|
|
AUTL
864
Autolus Therapeutics
AUTL
$394M
| $6.63M | 0.01% |
1,039,677
+542,724
| +109% | +$3.39M |
|
865
Canadian National Railway
CNI
$78.1B
| $6.59M | 0.01% |
+49,997
| New | +$6.39M |
|
866
US Bancorp
USB
$98.8B
| $6.58M | 0.01% |
+147,121
| New | +$6.21M |
|
867
Essex Property Trust
ESS
$18.8B
| $6.54M | 0.01% |
+26,696
| New | +$6.35M |
|
868
Campbell Soup
CPB
$6.74B
| $6.51M | 0.01% |
146,405
+85,696
| +141% | +$3.71M |
|
869
Pilgrim's Pride
PPC
$7.02B
| $6.5M | 0.01% |
189,432
-19,012
| -9% | -$570K |
|
|
AVDL
870
DELISTED
Avadel Pharmaceuticals
AVDL
| $6.48M | 0.01% |
383,641
+229,056
| +148% | +$3.41M |
|
|
NVEI
871
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $6.48M | 0.01% |
204,912
+59,859
| +41% | +$1.51M |
|
872
iShares US Home Construction ETF
ITB
$2.35B
| $6.47M | 0.01% |
+55,848
| New | +$5.86M |
|
|
CWAN
873
DELISTED
Clearwater Analytics
CWAN
| $6.46M | 0.01% |
+365,143
| New | +$6.78M |
|
874
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$50.4B
| $6.45M | 0.01% |
+88,200
| New | +$6.14M |
|
875
State Street Health Care Select Sector SPDR ETF
XLV
$42.3B
| $6.44M | 0.01% |
43,561
-283,094
| -87% | -$40.6M |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.